Clinical trial
Optimizing the Efficiency and Implementation of Cash Transfers to Improve Adherence to Antiretroviral Therapy, Phase II: Effectiveness Study
NCT04201353 is registered in ClinicalTrials.gov with University of California, Berkeley as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimizing the Efficiency and Implementation of Cash Transfers to Improve Adherence to Antiretroviral Therapy, Phase II: Effectiveness Study
- Lead sponsor
- University of California, Berkeley
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 9, 2020
- Completion date
- June 30, 2024
- Enrollment
- 1,984 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv (human immunodeficiency virus)